本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ascendis Pharma A/S

158.14
-0.9900-0.62%
盘前157.01-1.1300-0.71%08:07 EDT
成交量:43.28万
成交额:6,866.43万
市值:95.08亿
市盈率:-23.39
高:161.87
开:161.50
低:155.96
收:159.13
数据加载中...
2021/05/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/10

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/10

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/10/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/05/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/08

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/04/03

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/01

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]